Double blind, randomised controlled cross over trial comparing the antihypertensive effects of amiloride and spironolactone in black hypertensives with and without the T594M mutation

Update Il y a 4 ans
Reference: ISRCTN21821912

Woman and Man

Extract

Not provided at time of registration


Inclusion criteria

  • Hypertension

Links